Effects of sphingolipid metabolism disorders on endothelial cells

被引：17

作者：

Lai, Yali ^{[1
]}

Tian, Yue ^{[1
]}

You, Xintong ^{[1
]}

Du, Jiangnan ^{[1
]}

Huang, Jianmei ^{[1
]}

机构：

[1] Beijing Univ Chinese Med, Sch Tradit Chinese Mat Med, Beijing, Peoples R China

来源：

LIPIDS IN HEALTH AND DISEASE | 2022年 / 21卷 / 01期

基金：

中国国家自然科学基金;

关键词：

Sphingolipid metabolism; Endothelial cells; Sphingosine-1-phosphate; Sphingosine kinase; Ceramide; Serine; Ceramide kinase; Sphingosine-1-phosphate lyase; Cardiovascular disease; SPHINGOSINE-1-PHOSPHATE RECEPTOR 2; SPHINGOSINE KINASE; VASCULAR-PERMEABILITY; OVER-EXPRESSION; PRECURSOR CELLS; CERAMIDE; ACTIVATION; 1-PHOSPHATE; ANGIOGENESIS; DYSFUNCTION;

D O I：

10.1186/s12944-022-01701-2

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Many cardiovascular disorders, including atherosclerosis, hypertension, coronary heart disease, diabetes, etc., are characterized by endothelial cell dysfunction. Endothelial cell function is closely related to sphingolipid metabolism, and normal sphingolipid metabolism is critical for maintaining endothelial cell homeostasis. Sphingolipid metabolites or key enzymes in abnormal situation, including sphingosine, ceramide (Cer), sphingosine-1-phosphate (S1P), serine, sphingosine kinase (SPHK), ceramide kinase (Cerk), sphingosine-1-phosphate lyase (S1PL) etc., may have a protective or damaging effect on the function of endothelial cells. This review summarizes the effects of sphingolipid metabolites and key enzymes disordering in sphingolipid metabolism on endothelial cells, offering some insights into further research on the pathogenesis of cardiovascular diseases and corresponding therapeutic targets.

引用

页数：12

共 50 条

[31] Sphingolipid lysosomal storage disorders
Platt, Frances M.
NATURE, 2014, 510 (7503) : 68 - 75
[32] Effects the remyelination-promoting antibody rHIgM22 on sphingolipid metabolism in primary cultured glial cells
Grassi, S.
Prioni, S.
Cabitta, L.
Sonnino, S.
Prinetti, A.
JOURNAL OF NEUROCHEMISTRY, 2019, 150 : 140 - 140
[33] Sphingolipid lysosomal storage disorders
Frances M. Platt
Nature, 2014, 510 : 68 - 75
[34] Sphingolipid Signaling in Metabolic Disorders
Hla, Timothy
Dannenberg, Andrew J.
CELL METABOLISM, 2012, 16 (04) : 420 - 434
[35] Role of sphingolipid metabolism in neurodegeneration
Alaamery, Manal
Albesher, Nour
Aljawini, Nora
Alsuwailm, Moneera
Massadeh, Salam
Wheeler, Michael A.
Chao, Chun-Cheih
Quintana, Francisco J.
JOURNAL OF NEUROCHEMISTRY, 2021, 158 (01) : 25 - 35
[36] The meaning of Sphingolipid metabolism in mammacarcinoma
Ruckhaeberle, E.
Rody, A.
Geisslinger, G.
Holtrich, U.
Karn, T.
Kaufmann, M.
GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 : S176 - S176
[37] A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis
Quinville, Brianna M.
Deschenes, Natalie M.
Ryckman, Alex E.
Walia, Jagdeep S.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
[38] Identification of Sphingolipid Metabolism Perturbations in Endothelial Cells Induced by the Acid Sphingomyelinase Inhibitor Imipramine Using Stable Isotope Labeling and Targeted Lipidomics
Berdyshev, Evgeny
Justice, Matthew J.
Bronova, Irina
Schweitzer, Kelly S.
Petrache, Irina
FASEB JOURNAL, 2017, 31
[39] Sphingolipid metabolism and neuronal function
不详
PHARMACOLOGICAL REPORTS, 2005, 57 (03) : 425 - 425
[40] Computational modeling of sphingolipid metabolism
Wronowska, Weronika
Charzynska, Agata
Nienaltowski, Karol
Gambin, Anna
BMC SYSTEMS BIOLOGY, 2015, 9

← 1 2 3 4 5 →